- $87.63m
- -$65.22m
- $16.58m
Brief: Seer Posts Quarterly Loss Per Share Of 27 Cents
Seer Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Seer And SCIEX Sign Commercial Agreement To Offer End-To-End Unbiased Proteomics Solutions
Brief: Seer Reports Fourth Quarter And Full Year 2020 Financial Results
Seer Inc: Falls on discounted share offering
Brief: Seer Announces Pricing Of Upsized Public Offering Of Common Stock OF 3,750,000 Shares Of Class A Common Stock At $67 Per Share
Seer Inc: Falls on proposed common stock offering
Brief: Seer Announces Proposed Public Offering Of Common Stock
Brief: Maverick Capital Management Reports 10.4% Stake In Seer
Brief: Seer And Bruker Sign Commercial Agreement To Expand Market For Unbiased, Deep Proteomics
U.S. STOCKS ON THE MOVE-Boeing Co, Seer Inc, Mirum Pharma
Seer Inc: JPM sees sustainable growth ahead, initiates with 'overweight'
U.S. RESEARCH ROUNDUP- Aprea Therapeutics, Beyondspring, Cognizant Technology
Seer Inc: Shares jump over two-fold in Nasdaq debut
Brief: Seer Inc Says Pricing Of Its IPO Of 9.2 Million Shares Of Class A Common Stock At $19.00 Per Share
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:02 AM